4-Fluoroamphetamine (4-FA) intoxication results in exaggerated blood pressure effects compared to MDMA and

Femke M J Gresnigt1,2, Anouk Snik1, Eric J F Franssen3

  • 1Department of Emergency Medicine Onze Lieve Vrouwe Gasthuis Hospital AC Amsterdam the Netherlands.

Abstract

Insights

4-Fluoroamphetamine (4-FA) intoxication presents cardiovascular risks similar to MDMA and amphetamine, with higher rates of headache and hypertension. Severe 4-FA complications, including cardiomyopathy, occurred in 40% of mono-intoxicated patients.

Area of Science:

  • Cardiology
  • Toxicology
  • Emergency Medicine

Background:

  • 4-Fluoroamphetamine (4-FA) is a stimulant with effects similar to amphetamine and MDMA.
  • Severe cardiovascular complications, including cardiomyopathy and hemorrhage, have been linked to 4-FA use.
  • Understanding these risks is crucial for emergency department (ED) management.

Purpose of the Study:

  • To investigate cardiovascular symptoms and complications associated with 4-FA intoxication.
  • To compare these effects with those of MDMA and amphetamine in ED patients.

Main Methods:

  • Retrospective analysis of adult patients presenting to an Amsterdam ED between November 2015 and March 2020.
  • Inclusion criteria: self-reported intoxication with 4-FA, MDMA, or amphetamine.
  • Data collected: cardiovascular symptoms, vital signs, complications, interventions, admission rates, and Poisoning Severity Score (PSS).

Main Results:

  • A total of 582 patients were analyzed: 31 with 4-FA, 406 with MDMA, 100 with amphetamine, and 45 with cross-intoxications.
  • 4-FA mono-intoxicated patients reported more headaches (80%) and had higher systolic blood pressure (164 mmHg) compared to MDMA and amphetamine users.
  • Severe 4-FA cardiovascular complications included Takotsubo cardiomyopathy (3.2%), subarachnoid hemorrhage (3.2%), and hypertensive urgency (6.5%).

Conclusions:

  • 4-FA intoxication shares cardiovascular symptoms with MDMA and amphetamine but is more frequently associated with headache and hypertension.
  • Severe cardiovascular complications occurred in 40% of 4-FA mono-intoxication cases.
  • These findings highlight the significant cardiovascular risks of 4-FA, necessitating prompt medical attention.

Related Concept Videos

Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
283
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
224
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
315
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
824
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
260
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.4K